A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Monday 21 May 2012

Latest News on Medicinal Product SPCs: Alice de Pastors' report

With The SPC Blog's seminar almost upon us, here's a link to "Latest News on Medicinal Product SPCs in Europe", this being the 26th issue of Alice de Pastors' SPC News. It contains nine pages of fascinating data, enriched with colourful tables.

Thanks, Alice, for sharing all your hard work with us!

1 comment:

Howard M. Cohn & Associates said...

Any further authorization to place that active ingredient or that combination of active ingredients on the market as a medicinal product is to be regarded as a later authorization.